{"id":827,"date":"2024-05-22T12:04:46","date_gmt":"2024-05-22T12:04:46","guid":{"rendered":"https:\/\/demosites.io\/marketing-agency-gb\/?p=827"},"modified":"2026-01-04T22:09:46","modified_gmt":"2026-01-04T22:09:46","slug":"conquering-the-marketing-maze-creative-strategies-on-a-budget","status":"publish","type":"post","link":"https:\/\/www.h2founders.com\/cs\/conquering-the-marketing-maze-creative-strategies-on-a-budget\/","title":{"rendered":"\u010cesk\u00fd pr\u016flom ve sv\u011btov\u00e9 medic\u00edn\u011b: Molekul\u00e1rn\u00ed vod\u00edk je p\u0159edm\u011btem prvn\u00ed klinick\u00e9 studie sv\u00e9ho druhu v \u010cR"},"content":{"rendered":"<p class=\"wp-block-paragraph\">\u010cesk\u00e1 spole\u010dnost H2 Medical Technologies, sou\u010d\u00e1st skupiny H2 Global Group, dos\u00e1hla v\u00fdznamn\u00e9ho miln\u00edku. St\u00e1tn\u00ed \u00fastav pro kontrolu l\u00e9\u010div (S\u00daKL) schv\u00e1lil prvn\u00ed klinickou studii v \u010cesk\u00e9 republice zam\u011b\u0159enou na hodnocen\u00ed bezpe\u010dnosti inhalace molekul\u00e1rn\u00edho vod\u00edku u pacient\u016f s m\u00edrnou kognitivn\u00ed poruchou (MCI), co\u017e je stav, kter\u00fd \u010dasto p\u0159edch\u00e1z\u00ed Alzheimerov\u011b demenci.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"435\" height=\"267\" src=\"https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2930-1.png\" alt=\"\" class=\"wp-image-1045\" srcset=\"https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2930-1.png 435w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2930-1-300x184.png 300w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2930-1-18x12.png 18w\" sizes=\"auto, (max-width: 435px) 100vw, 435px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">David Mar\u0161\u00e1lek, zakladatel a CEO H2 Global Group, a PharmDr. Milan Kraj\u00ed\u010dek, \u0159editel v\u00fdzkumu, v\u00fdvoje a v\u00fdroby, hovo\u0159\u00ed o tom, jak se n\u00e1pad prom\u011bnil v projekt s glob\u00e1ln\u00edm dosahem. Rozhovor p\u0159in\u00e1\u0161\u00ed i post\u0159ehy japonsk\u00e9ho v\u011bdce profesora Shigeo Ohty, pova\u017eovan\u00e9ho za \u201eotce zakladatele\u201c vod\u00edkov\u00e9 biomedic\u00edny ve sv\u011bt\u011b.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Od dopl\u0148k\u016f stravy k medic\u00ednsk\u00e9mu plynu<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ot\u00e1zka: Jak jste se vlastn\u011b k molekul\u00e1rn\u00edmu vod\u00edku dostal?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">David Mar\u0161\u00e1lek: Byla to trochu n\u00e1hoda a trochu osud. V roce 2011 jsem za\u010dal pracovat v USA u firmy prod\u00e1vaj\u00edc\u00ed produkty zdrav\u00e9 v\u00fd\u017eivy, kde jsem potkal profesora Du\u0161ana Miljkovi\u010de, srbsk\u00e9ho v\u011bdce \u017eij\u00edc\u00edho v USA, kter\u00fd jako prvn\u00ed na sv\u011bt\u011b p\u0159edstavil vod\u00edkov\u00fd dopln\u011bk stravy. Stal se m\u00fdm prvn\u00edm \u201evod\u00edkov\u00fdm mentorem\u201c. Pozd\u011bji se ke mn\u011b p\u0159idali PharmDr. Milan Kraj\u00ed\u010dek, profesor Shigeo Ohta z Japonska, profesor J\u00e1n Slez\u00e1k ze Slovensk\u00e9 akademie v\u011bd, docent Michal Botek z Univerzity Palack\u00e9ho v Olomouci a dal\u0161\u00ed odborn\u00edci. D\u00edky nim jsem mohl poznat des\u00edtky v\u011bdc\u016f, l\u00e9ka\u0159\u016f a podnikatel\u016f z cel\u00e9ho sv\u011bta, kte\u0159\u00ed se v\u011bnuj\u00ed vyu\u017eit\u00ed molekul\u00e1rn\u00edho vod\u00edku v r\u016fzn\u00fdch oborech. Dnes m\u00e1m t\u00e9m\u011b\u0159 14 let zku\u0161enost\u00ed a velmi dobr\u00fd p\u0159ehled o tom, jak se tento specifick\u00fd obor glob\u00e1ln\u011b vyv\u00edj\u00ed.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Molekul\u00e1rn\u00ed vod\u00edk v medic\u00edn\u011b<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ot\u00e1zka: Co v\u00e1s p\u0159ivedlo k my\u0161lence vyu\u017eit\u00ed molekul\u00e1rn\u00edho vod\u00edku v medic\u00edn\u011b a z\u00e1m\u011bru registrovat zdravotnick\u00fd prost\u0159edek?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">David Mar\u0161\u00e1lek: V\u0161ichni odborn\u00edci, z\u00e1kazn\u00edci a partne\u0159i kolem m\u011b neust\u00e1le mluvili o molekul\u00e1rn\u00edm vod\u00edku. Zejm\u00e9na profesor Miljkovi\u010d mi u\u017e v za\u010d\u00e1tc\u00edch nab\u00eddl pomoc s v\u00fdzkumem a v\u00fdvojem, proto\u017ee ve vod\u00edku vid\u011bl obrovsk\u00fd potenci\u00e1l. Postupn\u011b jsem si uv\u011bdomil, \u017ee vod\u00edk nen\u00ed jen skv\u011bl\u00fd dopln\u011bk stravy, ale m\u00e1 re\u00e1ln\u00fd potenci\u00e1l pom\u00e1hat v medic\u00edn\u011b. Nejv\u011bt\u0161\u00ed v\u00fdzvou bylo sestavit t\u00fdm expert\u016f z cel\u00e9ho sv\u011bta, aby za\u010dali pracovat na jedn\u00e9 spole\u010dn\u00e9 my\u0161lence a c\u00edli pod jednotnou hlavi\u010dkou na\u0161\u00ed spole\u010dnosti H2 Global Group. To se n\u00e1m postupn\u011b poda\u0159ilo.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"nv-iframe-embed\"><iframe loading=\"lazy\" title=\"TK spole\u010dnosti H2 Medical Technologies ke schv\u00e1len\u00ed prvn\u00ed klinick\u00e9 studie S\u00daKL v \u010cR  inhalace H2\" width=\"1200\" height=\"675\" src=\"https:\/\/www.youtube.com\/embed\/PkSwcktnftw?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Cesta k prvn\u00ed klinick\u00e9 studii<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PharmDr. Milan Kraj\u00ed\u010dek, \u0159editel v\u00fdzkumu H2 Medical Technologies: \u201eNa\u0161e \u0159e\u0161en\u00ed p\u0159edstavuje zcela novou, neinvazivn\u00ed a bezpe\u010dnou metodu, kter\u00e1 m\u00e1 potenci\u00e1l st\u00e1t se pr\u016fkopnick\u00fdm p\u0159\u00edstupem, jeho\u017e \u00fa\u010dinky na neurodegenerativn\u00ed onemocn\u011bn\u00ed jsou nyn\u00ed p\u0159edm\u011btem klinick\u00e9ho testov\u00e1n\u00ed,\u201c vysv\u011btluje Dr. Kraj\u00ed\u010dek.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nyn\u00ed schv\u00e1len\u00e1 klinick\u00e1 studie bude ofici\u00e1ln\u011b zah\u00e1jena v lednu 2026. Z\u00fa\u010dastn\u00ed se j\u00ed p\u0159ibli\u017en\u011b 30 pacient\u016f ve v\u011bku 50\u201380 let, kte\u0159\u00ed budou inhalovat molekul\u00e1rn\u00ed vod\u00edk hodinu denn\u011b, p\u011bt dn\u00ed v t\u00fddnu po dobu t\u0159\u00ed m\u011bs\u00edc\u016f. N\u00e1sledovat bude f\u00e1ze sledov\u00e1n\u00ed po dobu dal\u0161\u00edch t\u0159\u00ed m\u011bs\u00edc\u016f, pot\u00e9 budou data vyhodnocena a cel\u00e1 studie publikov\u00e1na.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tato klinick\u00e1 studie stav\u00ed na men\u0161\u00edm japonsk\u00e9m v\u00fdzkumu na\u0161eho partnera, profesora Ohty, jeho\u017e pozitivn\u00ed v\u00fdsledky vedly k \u00fasp\u011b\u0161n\u00e9mu ud\u011blen\u00ed evropsk\u00e9ho patentu EP3701956B1 \u2013 \u201eProfylaktick\u00e9 nebo terapeutick\u00e9 \u010dinidlo pro demenci\u201c. I tento patent vlastn\u00ed H2 Global Group.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Profesor Shigeo Ohta na adresu molekul\u00e1rn\u00edho vod\u00edku \u010dasto podot\u00fdk\u00e1:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><em>\u201eMolekul\u00e1rn\u00ed vod\u00edk je unik\u00e1tn\u00ed v tom, \u017ee p\u016fsob\u00ed selektivn\u011b. Neutralizuje pouze \u0161kodliv\u00e9 voln\u00e9 radik\u00e1ly, ani\u017e by naru\u0161oval p\u0159irozen\u00e9 procesy v t\u011ble.\u201c<\/em><\/p>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\">Jak se vod\u00edk dost\u00e1v\u00e1 do t\u011bla a s \u010d\u00edm pom\u00e1h\u00e1<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">David Mar\u0161\u00e1lek: Vod\u00edk lze aplikovat r\u016fzn\u00fdmi zp\u016fsoby: pit\u00edm vod\u00edkem obohacen\u00e9 vody, prost\u0159ednictv\u00edm speci\u00e1ln\u00edch dopl\u0148k\u016f stravy, kosmetiky, koupel\u00ed nebo inhalac\u00ed pomoc\u00ed aplik\u00e1tor\u016f a inhala\u010dn\u00edch br\u00fdl\u00ed, podobn\u00fdch t\u011bm, kter\u00e9 se b\u011b\u017en\u011b pou\u017e\u00edvaj\u00ed pro inhalaci kysl\u00edku. T\u00e9m\u011b\u0159 t\u0159i tis\u00edce v\u011bdeck\u00fdch studi\u00ed popisuj\u00ed jeho mo\u017en\u00fd antioxida\u010dn\u00ed a protiz\u00e1n\u011btliv\u00fd potenci\u00e1l. Je proto neust\u00e1le zkoum\u00e1n pro sv\u016fj mo\u017en\u00fd vliv na bun\u011b\u010dnou rovnov\u00e1hu, z\u00e1n\u011btliv\u00e9 procesy a regeneraci. Tyto \u00fa\u010dinky jsou v\u0161ak nad\u00e1le p\u0159edm\u011btem v\u011bdeck\u00e9ho zkoum\u00e1n\u00ed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vod\u00edkov\u00e9 wellness procedury v sou\u010dasnosti vyu\u017e\u00edvaj\u00ed rehabilita\u010dn\u00ed centra, l\u00e9\u010debn\u00e9 l\u00e1zn\u011b, sportovn\u00ed kluby i kosmetick\u00e9 salony. Na\u0161e spole\u010dnost je dr\u017eitelem kl\u00ed\u010dov\u00fdch patent\u016f a u\u017eitn\u00fdch vzor\u016f na r\u016fzn\u00e9 aplikace vod\u00edku, v\u010detn\u011b t\u011bch pro o\u010di, u\u0161i a k\u016f\u017ei.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1.jpg\" alt=\"\" class=\"wp-image-1046\" srcset=\"https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1.jpg 800w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1-300x300.jpg 300w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1-150x150.jpg 150w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1-768x768.jpg 768w, https:\/\/www.h2founders.com\/wp-content\/uploads\/2024\/05\/1763051073_PRX10370M2932-1-12x12.jpg 12w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">\u010cesk\u00fd v\u00fdzkum se sv\u011btov\u00fdm p\u0159esahem<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">H2 Global Group spolupracuje s \u010desk\u00fdmi i zahrani\u010dn\u00edmi v\u011bdeck\u00fdmi institucemi. V r\u00e1mci p\u0159\u00edprav klinick\u00e9 studie byla nav\u00e1z\u00e1na spolupr\u00e1ce tak\u00e9 s renomovan\u00fdm neurologem profesorem MUDr. Davidem \u0160koloud\u00edkem, kter\u00fd p\u016fsob\u00ed na Ostravsk\u00e9 univerzit\u011b (L\u00e9ka\u0159sk\u00e9 fakult\u011b) a sou\u010dasn\u011b na 1. l\u00e9ka\u0159sk\u00e9 fakult\u011b Univerzity Karlovy v Praze. Je tak\u00e9 spojen s neurologick\u00fdmi ambulancemi a pracovi\u0161ti v Ostrav\u011b a Opav\u011b. Profesor \u0160koloud\u00edk je p\u0159edn\u00edm odborn\u00edkem na diagnostiku a l\u00e9\u010dbu cerebrovaskul\u00e1rn\u00edch onemocn\u011bn\u00ed, zejm\u00e9na prost\u0159ednictv\u00edm neurosonologie. Je autorem \u0159ady v\u011bdeck\u00fdch publikac\u00ed a dr\u017eitelem n\u011bkolika ocen\u011bn\u00ed za svou pr\u00e1ci v oboru.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dal\u0161\u00edm v\u00fdznamn\u00fdm \u010desk\u00fdm specializovan\u00fdm pracovi\u0161t\u011bm spolupracuj\u00edc\u00edm na jin\u00fdch v\u00fdzkumn\u00fdch projektech je Univerzita Palack\u00e9ho v Olomouci pod veden\u00edm docenta Michala Boteka, uzn\u00e1van\u00e9ho v\u011bdce v oboru kinantropologie, kter\u00fd se dlouhodob\u011b v\u011bnuje v\u00fdzkumu vlivu molekul\u00e1rn\u00edho vod\u00edku na lidsk\u00fd organismus p\u0159i fyzick\u00e9 z\u00e1t\u011b\u017ei.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mal\u00e1 zem\u011b, ale velk\u00e1 \u0161ance v medic\u00edn\u011b budoucnosti<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">V evropsk\u00e9m kontextu je sektor medic\u00ednsk\u00fdch startup\u016f st\u00e1le velmi m\u00e1lo rozvinut\u00fd. Podle anal\u00fdzy Deloitte vzrostl po\u010det HealthTech a MedTech startup\u016f v letech 2011\u20132020 p\u011btin\u00e1sobn\u011b, st\u0159edn\u00ed Evropa v\u0161ak st\u00e1le zaost\u00e1v\u00e1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Podle Davida Mar\u0161\u00e1lka to p\u0159edstavuje obrovskou p\u0159\u00edle\u017eitost: \u201eDnes v\u00edme, \u017ee segment MedTech a HealthTech startup\u016f nen\u00ed ve st\u0159edn\u00ed Evrop\u011b dostate\u010dn\u011b financov\u00e1n a \u017ee v \u010cesk\u00e9 republice existuje jen m\u00e1lo medic\u00ednsk\u00fdch startup\u016f na\u0161eho typu s takov\u00fdm glob\u00e1ln\u00edm p\u0159esahem. Jsme mal\u00e1 firma, kter\u00e1 z\u00edskala glob\u00e1ln\u00ed patenty na \u0159e\u0161en\u00ed probl\u00e9m\u016f tr\u00e1p\u00edc\u00edch celou civilizaci. To je unik\u00e1tn\u00ed \u0161ance nejen pro na\u0161i zemi, ale i pro investory, kte\u0159\u00ed s n\u00e1mi postupn\u011b p\u0159ich\u00e1zej\u00ed do kontaktu a t\u00e9to jedine\u010dn\u00e9 p\u0159\u00edle\u017eitosti vyu\u017e\u00edvaj\u00ed.\u201c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201eV\u011b\u0159\u00edme, \u017ee budoucnost medic\u00edny nespo\u010d\u00edv\u00e1 jen v l\u00e9\u010db\u011b nemoc\u00ed, ale p\u0159edev\u0161\u00edm v jejich prevenci. Na\u0161\u00edm c\u00edlem je, aby se \u010cesk\u00e1 republika stala m\u00edstem, odkud vzejde prvn\u00ed registrovan\u00fd zdravotnick\u00fd prost\u0159edek s molekul\u00e1rn\u00edm vod\u00edkem na sv\u011bt\u011b. Chceme dok\u00e1zat, \u017ee i mal\u00e1 zem\u011b m\u016f\u017ee ur\u010dovat sm\u011br sv\u011btov\u00e9 medic\u00edny.\u201c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201eTento \u00fasp\u011bch ukazuje, \u017ee \u010desk\u00e9 inovace mohou m\u011bnit sv\u011btovou medic\u00ednu. Spojujeme v\u00fdzkum, technologie a mezin\u00e1rodn\u00ed t\u00fdmy expert\u016f s jedin\u00fdm c\u00edlem: pomoci lidem p\u0159edch\u00e1zet ni\u010div\u00fdm dopad\u016fm civiliza\u010dn\u00edch chorob, v\u010detn\u011b Alzheimerovy choroby a dal\u0161\u00edch forem demence,\u201c dod\u00e1v\u00e1 David Mar\u0161\u00e1lek.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">V\u00fdzva pro dobrovoln\u00edky a p\u0159\u00edle\u017eitost pro investory<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Spole\u010dnost H2 Medical Technologies vyhl\u00e1sila ve\u0159ejnou v\u00fdzvu pro dobrovoln\u00edky, kte\u0159\u00ed se cht\u011bj\u00ed t\u00e9to studie z\u00fa\u010dastnit a spl\u0148uj\u00ed z\u00e1kladn\u00ed krit\u00e9ria: v\u011bk 50\u201380 let, celkov\u011b dobr\u00fd zdravotn\u00ed stav a diagn\u00f3za m\u00edrn\u00e9 kognitivn\u00ed poruchy (MCI) a\u017e m\u00edrn\u00e9 \u010di st\u0159edn\u011b t\u011b\u017ek\u00e9 demence. Ide\u00e1ln\u011b z Ostravy a okol\u00ed. Je t\u0159eba upozornit, \u017ee \u00fa\u010dast ve studii nezaru\u010duje \u017e\u00e1dn\u00fd zdravotn\u00ed benefit. Z\u00e1jemci se mohou hl\u00e1sit do 30. listopadu 2025 prost\u0159ednictv\u00edm e-mailu: david.skoloudik@H2medical.com.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mate\u0159sk\u00e1 spole\u010dnost H2 Global Group z\u00e1rove\u0148 nab\u00edz\u00ed investor\u016fm p\u0159\u00edle\u017eitost st\u00e1t se sou\u010d\u00e1st\u00ed tohoto unik\u00e1tn\u00edho projektu. \u201eNach\u00e1z\u00edme se v kl\u00ed\u010dov\u00e9m okam\u017eiku nejen pro na\u0161i firmu, ale i pro \u010deskou medic\u00ednu jako celek,\u201c uzav\u00edr\u00e1 David Mar\u0161\u00e1lek.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">H2 Global Group je \u010desk\u00e1 inovativn\u00ed skupina zam\u011b\u0159en\u00e1 prim\u00e1rn\u011b na v\u00fdzkum, v\u00fdvoj, v\u00fdrobu a vyu\u017eit\u00ed molekul\u00e1rn\u00edho vod\u00edku v medic\u00edn\u011b, prevenci a dlouhov\u011bkosti (longevity). Dnes p\u016fsob\u00ed ve v\u00edce ne\u017e deseti zem\u00edch sv\u011bta a spolupracuje s p\u0159edn\u00edmi univerzitami, l\u00e9ka\u0159sk\u00fdmi institucemi a v\u011bdeck\u00fdmi t\u00fdmy z Evropy, Japonska a USA. Skupina je dr\u017eitelem n\u011bkolika mezin\u00e1rodn\u00edch patent\u016f, v\u010detn\u011b t\u011bch v oblasti neinvazivn\u00ed aplikace vod\u00edku pro prevenci a terapii neurodegenerativn\u00edch onemocn\u011bn\u00ed. Spole\u010dnost usiluje o registraci prvn\u00edho zdravotnick\u00e9ho prost\u0159edku s molekul\u00e1rn\u00edm vod\u00edkem na sv\u011bt\u011b v bl\u00edzk\u00e9 budoucnosti.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Zdroj: <a href=\"https:\/\/www.ceskenoviny.cz\/tiskove\/zpravy\/cesky-prulom-do-svetove-mediciny-molekularni-vodik-je-tematem-prvni-klinicke-studie-sveho-druhu-v-cr\/2747234\">https:\/\/www.ceskenoviny.cz\/tiskove\/zpravy\/cesky-prulom-do-svetove-mediciny-molekularni-vodik-je-tematem-prvni-klinicke-studie-sveho-druhu-v-cr\/2747234<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>The Czech company H2 Medical Technologies, part of the H2 Global Group, has reached a significant milestone. The State Institute for Drug Control (S\u00daKL) has approved the first clinical trial in the Czech Republic to evaluate the safety of molecular hydrogen inhalation in patients with Mild Cognitive Impairment (MCI), a condition that often precedes Alzheimer&#8217;s&hellip;&nbsp;<a href=\"https:\/\/www.h2founders.com\/cs\/conquering-the-marketing-maze-creative-strategies-on-a-budget\/\" rel=\"bookmark\"><span class=\"screen-reader-text\">\u010cesk\u00fd pr\u016flom ve sv\u011btov\u00e9 medic\u00edn\u011b: Molekul\u00e1rn\u00ed vod\u00edk je p\u0159edm\u011btem prvn\u00ed klinick\u00e9 studie sv\u00e9ho druhu v \u010cR<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-marketing"],"_links":{"self":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/comments?post=827"}],"version-history":[{"count":3,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/827\/revisions"}],"predecessor-version":[{"id":1085,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/827\/revisions\/1085"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/media\/1054"}],"wp:attachment":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/media?parent=827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/categories?post=827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/tags?post=827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}